Alkermes (ALKS) Misses Q1 EPS by 18c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts ALKS Hot Sheet
Price: $45.89 +0.44%
Financial Fact:
Basic and diluted: -0.08
Today's EPS Names:
CIX, ARIS, COHR, More
Financial Fact:
Basic and diluted: -0.08
Today's EPS Names:
CIX, ARIS, COHR, More
Join SI Premium – FREE
Alkermes (NASDAQ: ALKS) reported Q1 EPS of $0.13, $0.18 worse than the analyst estimate of $0.31. Revenue for the quarter came in at $306.5 million versus the consensus estimate of $309.51 million.
For earnings history and earnings-related data on Alkermes (ALKS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ardent Health Partners, Inc. (ARDT) Tops Q3 EPS by 8c; offers guidance
- Steris (STE) Tops Q3 EPS by 26c ; Offers Guidance
- Alkermes (ALKS) PT Raised to $50 at H.C. Wainwright
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
